O'Neill Gilmore Neil Insider Trading
Get the latest insider transactions of O'Neill Gilmore Neil. O'Neill Gilmore Neil is EVP, R&D & CMO in Sarepta Therapeutics, Inc. ($SRPT) and SVP & Chief Medical Officer in Sarepta Therapeutics, Inc. ($SRPT) and Director in Unity Biotechnology, Inc. ($UBX). Discover the current value of O'Neill Gilmore Neil shares.
Address: 215 FIRST STREET CAMBRIDGE 02142MA
O'Neill Gilmore Neil is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | EVP, R&D & CMO, SVP & Chief Medical Officer | 29,070 | 847,971.90 |
| UBX | Unity Biotechnology, Inc. | Director | 0 |
Insider Trading Transactions of O'Neill Gilmore Neil
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnology, Inc. | O'Neill Gilmore Neil | Director | Option Exercise | 4.18 | 13,425 | 56,117 | 13,425 |
| Mar 05 2021 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Buy | 0.00 | 15,000 | 0 | 29,070 |
| Mar 05 2021 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | 87.11 | 60,000 | 5,226,600 | 60,000 |
| Dec 14 2020 | UBX | Unity Biotechnology, Inc. | O'Neill Gilmore Neil | Director | Option Exercise | 6.12 | 50,000 | 306,000 | 50,000 |
| Feb 28 2020 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Buy | 0.00 | 6,700 | 0 | 14,070 |
| Feb 28 2020 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | 114.47 | 37,500 | 4,292,625 | 37,500 |
| May 24 2019 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Buy | 0.00 | 12,000 | 0 | 12,000 |
| May 24 2019 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Sell | 119.31 | 4,630 | 552,405 | 7,370 |
| May 24 2019 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | 0.00 | 12,000 | 0 | 0 |
| Mar 04 2019 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | 145.48 | 55,000 | 8,001,400 | 55,000 |
| Jun 11 2018 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | SVP & Chief Medical O ... | Option Exercise | 96.23 | 100,000 | 9,623,000 | 100,000 |
| Jun 11 2018 | SRPT | Sarepta Therapeutics, Inc ... | O'Neill Gilmore Neil | SVP & Chief Medical O ... | Option Exercise | 0.00 | 12,000 | 0 | 12,000 |